Narmada Gelatines Ltd
₹ 397
-0.31%
03 May
- close price
About
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
Key Points
- Market Cap ₹ 240 Cr.
- Current Price ₹ 397
- High / Low ₹ 518 / 288
- Stock P/E 15.9
- Book Value ₹ 167
- Dividend Yield 0.00 %
- ROCE 15.7 %
- ROE 12.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 172%
Cons
- The company has delivered a poor sales growth of 10.2% over past five years.
- Company has a low return on equity of 7.69% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
107 | 122 | 130 | 134 | 131 | 113 | 118 | 126 | 134 | 135 | 157 | 191 | 182 | |
91 | 100 | 106 | 113 | 120 | 109 | 112 | 116 | 120 | 127 | 143 | 171 | 161 | |
Operating Profit | 15 | 22 | 24 | 21 | 11 | 4 | 5 | 9 | 14 | 8 | 15 | 20 | 21 |
OPM % | 14% | 18% | 19% | 16% | 8% | 3% | 5% | 7% | 11% | 6% | 9% | 10% | 12% |
3 | 2 | 3 | 4 | 3 | 6 | 4 | 5 | 6 | 6 | 3 | 2 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Profit before tax | 16 | 22 | 25 | 23 | 13 | 8 | 8 | 13 | 18 | 11 | 15 | 20 | 20 |
Tax % | 31% | 29% | 35% | 34% | 36% | 27% | 5% | 24% | 28% | 26% | 20% | 23% | |
11 | 15 | 16 | 16 | 8 | 6 | 8 | 10 | 13 | 8 | 12 | 15 | 15 | |
EPS in Rs | 18.43 | 25.67 | 27.10 | 25.62 | 13.70 | 10.10 | 13.29 | 16.63 | 21.29 | 13.98 | 20.40 | 25.26 | 24.89 |
Dividend Payout % | 16% | 13% | 12% | 14% | 29% | 40% | 30% | 60% | 47% | 72% | 49% | 396% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 10% |
3 Years: | 13% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | -1% |
5 Years: | 19% |
3 Years: | 13% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 26% |
3 Years: | 34% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 4 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 61 | 74 | 88 | 98 | 103 | 112 | 118 | 125 | 130 | 133 | 139 | 88 | 95 |
2 | 0 | 2 | 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | |
16 | 14 | 16 | 15 | 17 | 21 | 16 | 22 | 24 | 26 | 25 | 22 | 18 | |
Total Liabilities | 83 | 92 | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 115 | 119 |
23 | 25 | 24 | 23 | 23 | 22 | 25 | 24 | 26 | 29 | 27 | 28 | 27 | |
CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
Investments | 4 | 13 | 25 | 27 | 34 | 45 | 53 | 68 | 65 | 50 | 48 | 4 | 8 |
55 | 54 | 61 | 70 | 72 | 73 | 62 | 61 | 69 | 85 | 94 | 84 | 84 | |
Total Assets | 83 | 92 | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 115 | 119 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 15 | 10 | 6 | 7 | 7 | 9 | 12 | 5 | 3 | 2 | 14 | |
-1 | -10 | -10 | -0 | -7 | -2 | -2 | -5 | -4 | 6 | 10 | 44 | |
-0 | -4 | -1 | -3 | -2 | -5 | -3 | -1 | -9 | -7 | -6 | -67 | |
Net Cash Flow | 4 | 1 | -1 | 3 | -2 | 0 | 4 | 6 | -8 | 2 | 6 | -9 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 48 | 38 | 40 | 41 | 47 | 52 | 59 | 56 | 55 | 48 | 36 | 35 |
Inventory Days | 172 | 157 | 174 | 194 | 169 | 192 | 144 | 144 | 166 | 166 | 185 | 152 |
Days Payable | 44 | 33 | 33 | 21 | 23 | 52 | 40 | 62 | 63 | 62 | 57 | 41 |
Cash Conversion Cycle | 176 | 162 | 182 | 214 | 193 | 193 | 163 | 138 | 158 | 152 | 164 | 146 |
Working Capital Days | 102 | 89 | 102 | 120 | 124 | 146 | 127 | 101 | 109 | 115 | 119 | 97 |
ROCE % | 24% | 29% | 28% | 21% | 12% | 4% | 5% | 7% | 11% | 5% | 10% | 16% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 23 Apr
- Compliance- Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 As On 31St March 2024 10 Apr
-
Compliance Certificate For The Period Ended 31St March 2024
3 Apr - Compliance certificate under Regulation 7(3) of the SEBI(LODR) Regulations, 2015 for the Financial year ended 31.03.2024
- Closure of Trading Window 27 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 21 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water